...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Down 53% today

Someone bought 100 shares at .15 , moves up 50%  

Share
New Message
Please login to post a reply